UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 413

Sortiert nach

Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections

Journal of Virology, 2000-10, Vol.74 (19), p.9328-9332

2000

Volltextzugriff (PDF)

In Vitro Evolution of the Human Immunodeficiency Virus Type 1 Gag-Protease Region and Maintenance of Reverse Transcriptase Resistance following Prolonged Drug Exposure

Journal of Clinical Microbiology, 2001-03, Vol.39 (3), p.1124-1129

2001

Volltextzugriff (PDF)

Vpr and HIV-1 disease progression : R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients

AIDS (London), 2006-02, Vol.20 (4), p.567-574

2006

Volltextzugriff (PDF)

Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

Antimicrobial Agents and Chemotherapy, 2000-05, Vol.44 (5), p.1328-1332

2000

Volltextzugriff (PDF)

Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES

AIDS (London), 1999-06, Vol.13 (9), p.1144-1145

1999

Volltextzugriff (PDF)

In Vitro Inhibition of HIV-1 by Met-Sdf-1β Alone or in Combination with Antiretroviral Drugs

Antiviral therapy, 2000-09, Vol.5 (3), p.199-204

2000

Volltextzugriff (PDF)

Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine

Journal of acquired immune deficiency syndromes (1999), 1999-09, Vol.22 (1), p.101

1999

Volltextzugriff (PDF)

In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate

AIDS (London), 1997-09, Vol.11 (11), p.1406-1410

1997

Volltextzugriff (PDF)

New eco-friendly proposal for the crystallization of beet raw juice

Journal of cleaner production, 2005-12, Vol.13 (15), p.1447-1460

2005

Volltextzugriff (PDF)

Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates

Journal of antimicrobial chemotherapy, 2004-03, Vol.53 (3), p.464-468

2004

Volltextzugriff (PDF)

Entry and fusion inhibitors of HIV

Expert opinion on therapeutic patents, 2004-05, Vol.14 (5), p.733-748

2004

Volltextzugriff (PDF)

Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility

Journal of clinical virology, 2004, Vol.29 (1), p.27-32

2004

Volltextzugriff (PDF)

Tipranavir (PNU-140690) retains a potent antiviral in vitro activity against HIV-1 isolates derived from PI-naive or PI-experienced patients

AIDS (London), 2000-10, Vol.14, p.S20-S21

2000

Volltextzugriff (PDF)

Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects

Journal of antimicrobial chemotherapy, 2002-02, Vol.49 (2), p.427-429

2002

Volltextzugriff (PDF)

Therapy-driven viral evolution in multidrug-experienced HIV-1-infected patients

AIDS (London), 2000-10, Vol.14, p.S19-S19

2000

Volltextzugriff (PDF)

Virological response in multidrug-experienced hiv-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine

Antiviral therapy, 2001-03, Vol.6 (1), p.41-46

2001

Volltextzugriff (PDF)

Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure

Antiviral therapy, 1998-01, Vol.3 (4), p.203

1998

Volltextzugriff (PDF)

Lack of in vitro anti-gpl60 antibody production is a correlate of nonprogression among HIV type 1-infected individuals

AIDS research and human retroviruses, 1998-10, Vol.14 (15), p.1341-1343

1998

Volltextzugriff (PDF)

The proteins in the Rana esculenta embryo in normal development and in experimental conditions

Experimental cell research, 1955 (Suppl 3), p.287-293

1955

Volltextzugriff (PDF)

Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial

Antiviral therapy, 1997-01, Vol.2 (1), p.39

1997

Volltextzugriff (PDF)

In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs

Antiviral therapy, 2000-09, Vol.5 (3), p.199

2000

Volltextzugriff (PDF)

Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals

AIDS research and human retroviruses, 1998-10, Vol.14 (15), p.1341-1343

1998

Volltextzugriff (PDF)

Cytodifferentiation induced by ribonucleoproteins

Experientia, 1961-09, Vol.17 (9), p.395-396

1961

Volltextzugriff (PDF)

Molecular ontogenesis and molecular genetics in the crosses of toads

Experientia, 1961-01, Vol.17 (1), p.16-17

1961

Volltextzugriff (PDF)

On the zoological specificity of myosin and actin

Experientia, 1948-12, Vol.4 (12), p.480-481

1948

Volltextzugriff (PDF)

1 – 25 von 413

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(361)
Mit Volltextzugriff
(359)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(299)
Life Sciences & Biomedicine
(217)
Humans
(170)
Female
(93)
Male
(93)
Biological And Medical Sciences
(89)
Middle Aged
(76)
Adult
(75)
Medical Sciences
(71)
Surgery
(66)
Immunology
(63)
Physical Sciences
(63)
Technology
(55)
Transplantation
(51)
Aged
(48)
Animals
(45)
Fundamental And Applied Biological Sciences. Psychology
(41)
Instruments & Instrumentation
(33)
Physics
(31)
Pharmacology. Drug Treatments
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections

In Vitro Evolution of the Human Immunodeficiency Virus Type 1 Gag-Protease Region and Maintenance of Reverse Transcriptase Resistance following Prolonged Drug Exposure

Vpr and HIV-1 disease progression : R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients

Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES

In Vitro Inhibition of HIV-1 by Met-Sdf-1β Alone or in Combination with Antiretroviral Drugs

Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine

In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate

New eco-friendly proposal for the crystallization of beet raw juice

Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates

Entry and fusion inhibitors of HIV

Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility

Tipranavir (PNU-140690) retains a potent antiviral in vitro activity against HIV-1 isolates derived from PI-naive or PI-experienced patients

Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects

Therapy-driven viral evolution in multidrug-experienced HIV-1-infected patients

Virological response in multidrug-experienced hiv-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine

Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure

Lack of in vitro anti-gpl60 antibody production is a correlate of nonprogression among HIV type 1-infected individuals

The proteins in the Rana esculenta embryo in normal development and in experimental conditions

Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial

In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs

Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals

Cytodifferentiation induced by ribonucleoproteins

Molecular ontogenesis and molecular genetics in the crosses of toads

On the zoological specificity of myosin and actin

Suchergebnisse filtern